Stealth magnetic nanocarriers of siRNA as platform for breast cancer theranostics

被引:14
|
作者
Bruniaux, J. [1 ]
Ben Djemaa, S. [1 ]
Herve-Aubert, K. [1 ]
Marchais, H. [1 ]
Chourpa, I. [1 ]
David, S. [1 ]
机构
[1] Univ Tours, EA Nanomedicaments & Nanosondes 6295, F-37200 Tours, France
关键词
Chitosan; Poly-L-arginine; siRNA; SPION; Transfection; DOUBLE-STRANDED-RNA; IN-VIVO; TRANSFECTION EFFICIENCY; GOLD NANOPARTICLES; MOLECULAR-WEIGHT; DELIVERY; POLYETHYLENIMINE; INTERFERENCE; ARGININE; VITRO;
D O I
10.1016/j.ijpharm.2017.05.022
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The endogenous mechanism of RNA interference is more and more used in research to obtain specific down-regulation of gene expression in diseases such as breast cancer. Currently, despite the new fields of study open up by RNA interference, the rapid degradation of siRNA by nucleases and their negative charges prevent them from crossing cell membranes. To overcome these limitations, superparamagnetic iron oxide nanoparticles (SPIONs) represent a promising alternative for nucleic acid delivery. Previously, we reported the magnetic siRNA nanovectors (MSN) formulation using electrostatic assembly of (1) SPIONs, also able to act as contrast agents for magnetic resonance imaging (MRI), (2) siRNA and (3) chitosan aiming at their protection and enhancing their transfection efficacy. However, these nanoparticles displayed low stability in biological suspensions and inefficient transfection of active siRNA. This work aimed at upgrading MSN to Stealth MSN (S-MSN) by adding a polyethylene glycol coating to ensure colloidal stability and stealth properties. Furthermore, another polymer (poly-L-arginine) was added for efficient siRNA transfection and the quantitative composition of the formulation was adapted for biological purposes. Results showed that S-MSN provide high siRNA complexation and protection against enzymatic degradation. Green fluorescent protein (GFP) specific down-regulation on MDAMB231/GFP cells was comparable to that of commercially available reagents, without observable cytotoxicity. According to our works, S-MSN appears as an effective formulation for in vitro siRNA specific delivery. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:660 / 668
页数:9
相关论文
共 50 条
  • [1] Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells
    Oliveira, Ana C. N.
    Raemdonck, Koen
    Martens, Thomas
    Rombouts, Koen
    Simon-Vazquez, Rosana
    Botelho, Claudia
    Lopes, Ivo
    Lucio, Marlene
    Gonzalez-Fernandez, Africa
    Real Oliveira, M. Elisabete C. D.
    Gomes, Andreia C.
    Braeckmans, Kevin
    ACTA BIOMATERIALIA, 2015, 25 : 216 - 229
  • [2] Nanoemulsion-encapsulated magnetic nanocarriers for cancer theranostics
    Fedorov, V.
    Yakovleva, L.
    Nikolaev, B.
    Yudintceva, N.
    Shevtsov, M.
    FEBS OPEN BIO, 2021, 11 : 276 - 276
  • [3] Polymeric nanocarriers for cancer theranostics
    Vijayan, Vineeth M.
    Muthu, Jayabalalan
    POLYMERS FOR ADVANCED TECHNOLOGIES, 2017, 28 (12) : 1572 - 1582
  • [4] Multicompartmental nanocarriers for cancer theranostics
    Misra, Asish C.
    Bhaskar, Srijanani
    Rahmani, Sahar
    Lahann, Joerg
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [5] Magnetic nanoparticles: a novel platform for cancer theranostics
    Singh, Abhalaxmi
    Sahoo, Sanjeeb K.
    DRUG DISCOVERY TODAY, 2014, 19 (04) : 474 - 481
  • [6] Non-viral nanocarriers for siRNA delivery in breast cancer
    Zhang, Jing
    Li, Xiang
    Huang, Leaf
    JOURNAL OF CONTROLLED RELEASE, 2014, 190 : 440 - 450
  • [7] Non-viral nanocarriers for siRNA delivery in breast cancer
    Zhang, Jing
    Li, Xiang
    Huang, Leaf
    Journal of Controlled Release, 2014, 190 : 440 - 450
  • [8] Magnetically responsive nanocarriers for cancer theranostics
    Nie, Zhihong
    Yang, Kuikun
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [9] Chitosan: A versatile bio-platform for breast cancer theranostics
    Madamsetty, Vijay Sagar
    Tavakol, Shima
    Moghassemi, Saeid
    Dadashzadeh, Arezoo
    Schneible, John D.
    Fatemi, Iman
    Shirvani, Abdolsamad
    Zarrabi, Ali
    Azedi, Fereshteh
    Dehshahri, Ali
    Aghaei Afshar, Abbas
    Aghaabbasi, Kian
    Pardakhty, Abbas
    Mohammadinejad, Reza
    Kesharwani, Prashant
    Journal of Controlled Release, 2022, 341 : 733 - 752
  • [10] Chitosan: A versatile bio-platform for breast cancer theranostics
    Madamsetty, Vijay Sagar
    Tavakol, Shima
    Moghassemi, Saeid
    Dadashzadeh, Arezoo
    Schneible, John D.
    Fatemi, Iman
    Shirvani, Abdolsamad
    Zarrabi, Ali
    Azedi, Fereshteh
    Dehshahri, Ali
    Afshar, Abbas Aghaei
    Aghaabbasi, Kian
    Pardakhty, Abbas
    Mohammadinejad, Reza
    Kesharwani, Prashant
    JOURNAL OF CONTROLLED RELEASE, 2022, 341 : 733 - 752